If your company sells, manufactures, or ships CBD products internationally, Hong Kong is a hard stop. Since 1 February 2023, Hong Kong has classified cannabidiol (CBD) as a dangerous drug under the Dangerous Drugs Ordinance (Cap. 134)—and enforcement has remained active through 2024 and 2025, including seizures at Hong Kong International Airport and scrutiny of parcels.

For compliance teams, the practical takeaway in 2025 (and continuing into 2026) is simple: do not ship CBD to Hong Kong, do not route CBD through Hong Kong, and do not allow employees to carry CBD into Hong Kong—even during “just a layover.” This post translates Hong Kong’s legal posture into an operational playbook for Hong Kong CBD ban 2025 compliance across e‑commerce, global logistics, and corporate travel.

Informational only, not legal advice.

Hong Kong’s 2025 legal position: CBD is treated like other “dangerous drugs”

Hong Kong’s government has repeatedly emphasized that CBD is controlled under Cap. 134 and that members of the public and businesses should not import, bring in, or deal with products containing CBD.

What changed (and when)

• 1 February 2023: The legislative control of CBD as a dangerous drug took effect. Hong Kong Customs announced it would take strict enforcement action from that date forward, including interdiction of import and transit movements. Source: Hong Kong government press release (via Info.gov.hk) and Hong Kong Customs.
• https://www.info.gov.hk/gia/general/202301/27/P2023012700369.htm
• https://www.customs.gov.hk/en/customs-announcement/press-release/index_id_3635.html

Penalties companies must model as “severe”

Hong Kong’s public guidance highlights substantial criminal exposure:

• Trafficking (including importing and exporting) and illicit manufacture of CBD: maximum penalty of HK$5 million fine and life imprisonment.
• https://www.info.gov.hk/gia/general/202301/27/P2023012700369.htm
• Possession and consumption: government travel‑facing warnings cite a maximum penalty of 7 years’ imprisonment and HK$1 million fine.
• https://www.hketobrussels.gov.hk/news/2023/02/01/cannabidiol-cbd-listed-as-a-dangerous-drug-visitors-warned-not-to-bring-any-cbd-products-to-hong-kong

Also see the official ordinance text:

• https://www.elegislation.gov.hk/hk/cap134

Why enforcement risk stays high in 2025: airport and parcel interdictions are core channels

For global brands, the operational risk isn’t hypothetical. Hong Kong Customs’ communications around CBD control explicitly called out stepped‑up enforcement to intercept import and transit movements across channels.

Airports: passenger baggage remains a recurring enforcement setting

Hong Kong Customs has publicized airport seizures of drug shipments as part of ongoing risk‑based targeting of inbound passengers. Even when a press release is not CBD‑specific, the enforcement posture and airport screening intensity matter for corporate travelers carrying any restricted item.

In the early days of CBD control, Hong Kong Customs also publicized seizures of suspected CBD oil in enforcement actions that included the airport.

• https://www.customs.gov.hk/en/customs-announcement/press-release/index_id_3643.html

The broader airport enforcement pattern is also apparent from 2025 airport seizure releases (again, not necessarily CBD‑specific, but indicative of Customs’ routine airport interdiction operations):

• https://www.customs.gov.hk/en/customs-announcement/press-release/index_id_4714.html

Mail and parcels: e‑commerce shipments are a realistic point of failure

Hong Kong authorities have repeatedly warned consumers not to order restricted products online or bring them back from overseas. Hong Kong Customs stated it would step up enforcement to intercept import and transit movements “in various channels,” which for compliance purposes includes express couriers and postal packets.

• https://www.info.gov.hk/gia/general/202301/27/P2023012700369.htm

Separately, the government’s food safety content has emphasized ingredient vigilance and the risks of ordering products online that may contain controlled cannabinoids, noting CBD control took effect on 1 February 2023.

• https://www.cfs.gov.hk/english/multimedia/multimedia_pub/multimedia_pub_fsf_150_04.html

Cross‑border e‑commerce: why “we don’t market to Hong Kong” is not enough

Many global brands believe the risk is limited to intentionally shipping to Hong Kong addresses. In practice, exposure often comes from:

• Customer‑initiated forwarding (third‑party freight forwarders)
• Marketplace fulfillment programs (multi‑node inventory)
• Returns processing that routes through a Hong Kong hub
• Auto‑routing by carriers through Hong Kong even when the destination is elsewhere

Because Hong Kong treats CBD as a dangerous drug, your control framework should treat Hong Kong like a jurisdiction where CBD is categorically prohibited for general commerce.

Cart and checkout controls for “Hong Kong CBD ban 2025 compliance”

At minimum:

• Hard block Hong Kong shipping addresses for CBD SKUs (including any SKU that could contain CBD as an ingredient).
• Block billing and shipping mismatches where a Hong Kong address appears in either field.
• Create a forwarder and reshipper block list (common in APAC) and treat “ship‑to forwarder” orders as high risk.
• Require HS code + ingredient keyword screening at order capture (e.g., “cannabidiol,” “CBD,” “hemp extract,” “full spectrum,” “broad spectrum”).
• Build returns rules that prevent a Hong Kong consolidation address from being used as a reverse‑logistics node.

Marketplace and 3PL governance controls

If you sell through marketplaces or use a 3PL:

• Contractually prohibit any Hong Kong fulfillment or transshipment for CBD products.
• Require the 3PL to implement SKU‑level country blocks and provide evidence (screenshots, configuration exports, or audit reports).
• Confirm how the 3PL handles cross‑dock and hub‑and‑spoke routing in Asia.

The transshipment trap: “not destined for Hong Kong” can still create Hong Kong touchpoints

Hong Kong’s role as an air cargo hub creates a compliance problem: a shipment moving from (A) to (B) can still transit Hong Kong.

Hong Kong Customs’ own statement that it will intercept import and transit movements is the key compliance signal here.

• https://www.info.gov.hk/gia/general/202301/27/P2023012700369.htm

How transshipment happens in real operations

Common scenarios:

• Express courier automatically routes APAC parcels through a Hong Kong hub for linehaul efficiency.
• A freight forwarder books air cargo with a Hong Kong connection because it is cheaper or faster.
• A consolidated shipment is moved to Hong Kong for breakdown and re‑labeling.

Practical takeaway

For CBD products, you should treat Hong Kong as a no‑transit jurisdiction and enforce that in routing rules.

Corporate travel: employee carry‑in risk is one of the most preventable failures

Business travelers routinely carry wellness items, topical products, gummies, capsules, or cosmetics without thinking. In Hong Kong, that casual behavior can become a criminal matter.

Hong Kong government communications have explicitly warned travelers not to bring CBD products into Hong Kong, and Customs has stated it will continue safeguarding against carrying dangerous drugs through boundary control points.

• https://www.hketobrussels.gov.hk/news/2023/02/01/cannabidiol-cbd-listed-as-a-dangerous-drug-visitors-warned-not-to-bring-any-cbd-products-to-hong-kong
• https://www.info.gov.hk/gia/general/202212/19/P2022121600631.htm

What a compliant corporate travel policy should say (minimum viable)

Add a Hong Kong‑specific policy section that:

• Prohibits employees and contractors from bringing CBD products into Hong Kong, including in carry‑on, checked baggage, or couriered personal effects.
• Treats layovers and airside transits as covered travel, because luggage may be inspected and local law applies at the border.
• Requires employees to self‑certify they are not carrying restricted items before travel to high‑risk hubs.
• Provides a clear escalation channel: “If you discover you have a restricted item before travel, contact Compliance/Travel Risk immediately.”

A red‑flag checklist for global logistics & compliance teams

Use this as a working checklist for Hong Kong CBD ban 2025 compliance.

Red flags in product and data

• Ingredient list includes cannabidiol, CBD, “hemp extract,” “phytocannabinoids,” “full spectrum,” or “broad spectrum.”
• Label claims imply CBD even if the ingredient list is unclear.
• COA indicates any cannabinoid content.
• Customer notes mention “CBD,” “hemp,” “calm,” “relax,” or similar.

Red flags in routing and fulfillment

• Carrier service selected has an APAC hub in Hong Kong.
• Air waybill shows a Hong Kong connection.
• 3PL uses Hong Kong for cross‑dock, consolidation, or returns.
• Order originates from a marketplace program with opaque inventory placement.

Red flags in customer profile

• Freight forwarder address, mailbox service, or known reshipper.
• Shipping destination is Japan or Singapore but the cheapest route offered transits Hong Kong.

Controls to implement immediately

• No‑HK routing rule: prohibit Hong Kong as origin, destination, or transit point for CBD SKUs.
• Geo‑fencing in e‑commerce: hard block Hong Kong at checkout.
• Carrier instructions: add a “NO TRANSIT VIA HONG KONG” note for relevant lanes (where carriers will accept it) and require written confirmation of routing.
• Order monitoring: alerts when Hong Kong appears anywhere in shipping metadata.
• Employee travel SOP: pre‑trip reminders for high‑risk hubs.

Neighboring regimes comparison: avoid “accidental routing” through strict hubs

Companies often manage compliance country‑by‑country, but logistics networks are regional. Hong Kong’s stance is not unique in Asia; it sits within a cluster of strict or technical regimes where “trace” and “residue” issues can matter.

Japan: technical standards and extremely low THC tolerance concepts

Japan’s CBD environment has historically hinged on strict rules around THC and product sourcing, and industry reporting indicates Japan has been moving toward extremely low numeric thresholds for THC in certain product categories. Because compliance can depend on analytical sensitivity and “not detected” concepts, Japan‑bound shipments that accidentally route through Hong Kong multiply risk.

For updates, monitor Japan’s Ministry of Health, Labour and Welfare (MHLW) and official publications. Industry coverage (not a substitute for primary law) includes:

• https://businessofcannabis.com/japan-issues-update-on-new-thc-limits-in-cbd-products-which-remain-strictest-in-the-world/

Singapore: explicit zero‑tolerance framing

Singapore’s Central Narcotics Bureau states that hemp and CBD oil products are treated as Class A controlled substances and warns that products may contain controlled drugs despite labels.

• https://www.cnb.gov.sg/singapore-drug-situation/myths-and-facts-about-drugs/cannabis/faqs-about-hemp-and-cbd-oil-products/

Operational implication for APAC networks

• Build an APAC routing map that designates Hong Kong and Singapore as no‑ship/no‑transit for CBD.
• For Japan, require lane‑specific compliance review and confirm documentation/testing expectations with counsel and import specialists.

What to do if you discover a Hong Kong touchpoint in your supply chain

When a company discovers that a carrier or forwarder routed a restricted product through Hong Kong, speed and documentation matter.

Immediate steps (operations + compliance)

• Place the shipment on hold and request full routing details (master air waybill, house air waybill, scan events).
• Notify internal compliance leadership and document a timeline.
• Suspend the lane or carrier configuration until a no‑HK routing control is validated.

Program fixes (so it doesn’t happen again)

• Add Hong Kong as a prohibited node in TMS/OMS routing rules.
• Re‑train customer support and logistics coordinators.
• Audit all APAC carrier products for hub routing.

Key takeaways

• Hong Kong treats CBD as a dangerous drug under Cap. 134 and maintains an enforcement posture that includes import and transit interdiction.
• The most common corporate failure modes are transshipment routing, e‑commerce forwarding, and employee travel carry‑in.
• A defensible compliance posture in 2025 is to implement hard shipping blocks, no‑transit routing rules, and an explicit corporate travel prohibition for Hong Kong.

Stay current and reduce cross‑border risk

Hong Kong enforcement and APAC routing practices can change quickly. For ongoing monitoring, bookmark Hong Kong Customs press releases and Hong Kong government updates:

• Hong Kong Customs press releases: https://www.customs.gov.hk/en/customs-announcement/press-release/
• Hong Kong government news (Info.gov.hk): https://www.info.gov.hk/
• Hong Kong e‑Legislation (Cap. 134): https://www.elegislation.gov.hk/hk/cap134

To operationalize cannabis compliance, licensing, and shipping controls across jurisdictions—especially for complex cross‑border e‑commerce—use https://cannabisregulations.ai/ to build defensible compliance workflows, monitor rule changes, and reduce enforcement exposure.